GEN Exclusives

More »

GEN News Highlights

More »
Aug 16, 2007

Progen Employs Quintiles to Assist with Phase III Trial of Oncology Therapy

  • Progen Pharmaceuticals (www.progen. will use Quintiles’ ( services for clinical development-related projects. This agreement includes the execution of the Phase III trial of anticancer drug PI-88 for the treatment of primary liver cancer (hepatocellular carcinoma). Progen says that it is on track to initiate recruitment in the fourth quarter of 2007.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »